Support the news

The Prostate Test45:56
Download

Play
Photo: Flickr/Vidiot
Photo: Flickr/Vidiot

Huge studies came out last week on the number-one cancer issue in men’s health. Women wrestle with breast cancer. Men: prostate.

It’s generally slow-growing. It can show up even among twenty-year-olds. And it can be an obsession for men over 50.

But how aggressive should we be in screening and treating? In cutting it out? The upside: it may save your life. The downside risk: incontinence and impotence, and expensive intervention that may not have been necessary.

This hour, On Point: The latest on prostate cancer, and whether the treatment is worse than the disease.

You can join the conversation. Have you been diagnosed with prostate cancer? Have you gone for the full treatment? Or hung back? What do you make of the new studies?Guests:

Joining us from Berlin, Germany, is Dr. Gerald Andriole, chief urologic surgeon at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis. He led the U.S. study of 77,000 men published on March 18 in the New England Journal of Medicine. A European study was also published in the NEJM last week.

Joining us from Cleveland, Ohio, is Dr. Stephen Jones, chairman of the department of regional urology at the Glickman Urological Institute at the Cleveland Clinic.

From Wilmington, N.C., we're joined by Dr. Nortin Hadler, professor of medicine and microbiology & immunology at the University of North Carolina School of Medicine. He is author of "Worried Sick: A Prescription for Health in an Overtreated America."

This program aired on March 23, 2009.

+Join the discussion
TwitterfacebookEmail

Support the news